Latest News:

More support for lutein, zeaxanthin protection from AMD
Tuesday, 6th May 2008

16-Aug-2006 - A stable intake of the carotenoids, lutein and zeaxanthin, could reduce the risk of age related macular degeneration by 43 per cent in women under 75, says a new cohort study.
...more

LUTEIN STORY
Monday, 7th April 2008

LUTEIN AND ZEAXANTHIN White Papers
...more

Cardiovascular Health

Cardiovascular Health Frequently Asked Questions

Can lutein help promote good cardiovascular health?

The cardio-protective role of carotenoids stems from the finding in epidemiological studies that persons with higher intakes of fruits and vegetables are at a reduced risk of coronary heart disease and stroke . Mediterranean populations have the lowest mortality rate from coronary heart disease in Europe. When foods common to the Mediterranean diet were analyzed for carotenoid content, high levels of lutein were detected and correlated well with the relatively high serum levels of lutein found in Greek people . The authors of this study theorize this may contribute to the lower mortality rate from coronary heart disease exhibited by this group.

Price: $75.00 per 60
          day bottle size


Please Enter the Quantity:



How does lutein promote cardiovascular health?

The exact mechanism of lutein's suggested ability to protect against cardiovascular disease is unknown at this time; however, three studies (collectively known as The Los Angeles Atherosclerosis Study) published by Dr. James Dwyer at the University of Southern California suggest that the protective effect of lutein is at least partially due to an antioxidant mechanism.** First, Dr. Dwyer's research indicated that as plasma lutein concentration increased, carotid artery intima-media thickness decreased in women and men. Carotid artery intima-media thickness has been strongly associated with the risk of both coronary heart disease and stroke. Next, he incubated endothelial and smooth muscle cells from human aortas with lutein and found a significant inhibition of the inflammatory response of monocytes to LDL (Low Density Lipoprotein) trapped in the artery wall. Finally, Dr. Dwyer's research found that in mice known to develop severe atherosclerotic lesions, lutein supplementation significantly reduced the size of atherosclerotic lesions in the aortic arch.** In addition, lutein significantly reduced markers of oxidative stress and plasma VLDL+IDL (Very Low Density Lipoprotein + Intermediate Density Lipoprotein) levels.** These results suggest that there may be a positive effect of lutein on the progression of early atherosclerosis.**

** These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.